Strong link between the alpha1‐antitrypsin PiZ allele and Wegener's granulomatosis
- 1 November 1994
- journal article
- Published by Wiley in Journal of Internal Medicine
- Vol. 236 (5) , 543-548
- https://doi.org/10.1111/j.1365-2796.1994.tb00842.x
Abstract
Objectives. To ascertain whether a relationship exists between the PiZ alpha1-antitrypsin (α1AT) variant and antineutrophil cytoplasm antibodies (ANCA)-positive vasculitis in a large group of Swedish patients, and whether analysis for the presence of the PiZ variant might be useful for diagnostic or prognostic purposes. Design. Retrospective cross-sectional study. Setting. The Department of Internal Medicine, Malmö General Hospital, and the Department of Nephrology, University of Lund, Sweden. Subjects and main outcome measures. Serum samples from 105 proteinase 3-ANCA-positive patients were analysed using an elisa with a monoclonal antibody specific for the PiZ-gene product. Complete clinical data were retrieved for 84% (88/105) of the patients, for diagnosis and survival analysis. Results. We identified 17 heterozygotes and one homozygote (P < 0.0001). All 88 patients with available clinical data were considered to have some form of microscopic vasculitis including 66 (75%) diagnosed as having Wegener's granulomatosis (WG), of whom 15 (23%) were PiZ heterozygotes (odds ratio 6.0, 95% confidence interval 3–10). There were no significant differences between PiZ carriers and noncarriers in sex distribution, mean age at onset of disease, interval between onset and inclusion in the study, or in median duration of follow-up (P > 0.2 for all comparisons). During follow-up, 38% (6/16) of the PiZ heterozygotes died, compared with 17% (11/66) of noncarriers of the variant (P = 0.02), which suggests that PiZ heterozygosity may be a marker of poor prognosis. PiZ heterozygotes with systemic vasculitis would not appear to be identifiable by their pretreatment plasma α1AT concentrations, as all such patients in the present study had concentrations within or above the normal range. Conclusion. We conclude that heterozygotes for the PiZ variant of the α1AT gene are at greater risk of than the general population of developing WG. Knowledge of such a genetic factor may not only aid our understanding of the mechanism involved in this illness but may also serve as significant prognostic factor in following the course of the disease.Keywords
This publication has 20 references indexed in Scilit:
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Mechanisms of tissue destruction and cellular activation in rheumatoid arthritisCurrent Opinion in Rheumatology, 1992
- The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosisArthritis & Rheumatism, 1990
- Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.Journal of Clinical Investigation, 1990
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986
- The role of α1-antitrypsin deficiency in the pathogenesis of immune disordersClinical Immunology and Immunopathology, 1985
- AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSISThe Lancet, 1985
- alpha1-Antitrypsin deficiency associated with persistent cutaneous vasculitis. Occurrence in a child with liver diseaseArchives of Dermatology, 1978
- THE α1-ANTITRYPSIN PHENOTYPE MZ IN ACUTE ANTERIOR UVEITISThe Lancet, 1978
- The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin DeficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1963